$23.35

-0.13 (-0.55%)

Weekly Expected Move ±5.1%

$20 $21 $23 $24 $25

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 43 · $918.5M mcap · 38M float · 1.90% daily turnover · Short 48% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$726M +3.6% ▲

5Y CAGR: +11.1%

Gross Profit

$519M -2.1% ▼

5Y CAGR: +10.7%

Operating Income

$28M +138.3% ▲

5Y CAGR: -9.5%

Net Income

$7M +107.1% ▲

5Y CAGR: -45.4%

EPS (Diluted)

$0.16 +107.4% ▲

5Y CAGR: -45.5%

EBITDA

$119M +309.1% ▲

5Y CAGR: +13.4%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$542M	$667M	$675M	$701M	$726M
YoY Growth	+28.7%	+23.1%	+1.2%	+3.9%	+3.6%
Cost of Revenue	$140M	$199M	$185M	$170M	$207M
Gross Profit	$401M	$468M	$490M	$531M	$519M
Gross Margin	74.1%	70.1%	72.6%	75.7%	71.5%
R&D Expenses	$56M	$85M	$76M	$82M	$117M
SG&A Expenses	$199M	$255M	$269M	$294M	$369M
Operating Expenses	$311M	$408M	$403M	$604M	$491M
Operating Income	$90M	$60M	$88M	-$73M	$28M
Operating Margin	16.6%	9.0%	13.0%	-10.5%	3.9%
Interest Expense	$29M	$36M	$17M	$17M	$17M
Income Before Tax	$56M	$13M	$62M	-$63M	$17M
Tax Expense	$14M	-$3M	$20M	$36M	$10M
Net Income	$42M	$16M	$42M	-$100M	$7M
Net Margin	7.8%	2.4%	6.2%	-14.2%	1.0%
EPS (Diluted)	$0.92	$0.34	$0.89	$-2.15	$0.16
EBITDA	$114M	$140M	$155M	$29M	$119M
Shares Outstanding	46M	47M	52M	46M	45M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$178M	$169M	$187M	$169M	$181M	$180M	$197M	$177M
Cost of Revenue	$44M	$39M	$40M	$34M	$41M	$34M	$40M	$36M
Gross Profit	$134M	$130M	$147M	$135M	$140M	$145M	$157M	$141M
Gross Margin	75.1%	76.9%	78.7%	79.7%	77.4%	80.9%	79.5%	79.5%
R&D Expenses	$20M	$19M	$24M	$25M	$28M	$26M	$37M	$28M
SG&A Expenses	$68M	$74M	$80M	$87M	$89M	$92M	$102M	$94M
Operating Expenses	$106M	$269M	$123M	$133M	$132M	$139M	$153M	$136M
Operating Income	$28M	-$140M	$25M	$2M	$8M	$6M	$3M	$5M
Operating Margin	15.9%	-82.8%	13.2%	1.2%	4.7%	3.5%	1.6%	2.6%
Interest Expense	$3M	$5M	$4M	$5M	$5M	$4M	$3M	$3M
Income Before Tax	$37M	-$139M	$26M	$9M	-$2M	$10M	$571K	$5M
Tax Expense	$18M	$5M	$9M	$4M	$3M	$4M	-$1M	$2M
Net Income	$19M	-$143M	$16M	$5M	-$5M	$5M	$2M	$3M
Net Margin	10.6%	-85.1%	8.6%	2.8%	-2.7%	3.0%	0.8%	1.6%
EPS (Diluted)	$0.39	$-3.11	$0.34	$0.10	$-0.11	$0.12	$0.04	$0.07
EBITDA	$59M	-$115M	$51M	$34M	$29M	$34M	$25M	$30M
Shares Outstanding	51M	46M	49M	47M	45M	44M	43M	41M

PCRX NASDAQ